OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/microcap.htm today to join this growing community.
Our Stocks to Watch tomorrow include Opexa Therapeutics Inc. (Nasdaq: OPXA), Speedus Corp. (Nasdaq: SPDE), Land Star Inc. (OTC: LDSR) and Optigenex Inc. (OTC: OPGX). Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts.
OPEXA THERAPEUTICS INCORPORATED (NASDAQ: OPXA) "Up 326.75% on Friday" Opexa Therapeutics, Inc. is dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases. The Company’s leading therapy, Tovaxin, is an individualized cellular immunotherapy treatment in Phase IIb clinical development for Multiple Sclerosis (MS). Tovaxin is derived from T-cells isolated from peripheral blood, expanded ex vivo, and reintroduced into the patients via subcutaneous injections. This process triggers a potent immune response against specific subsets of autoreactive T-cells known to attack myelin and, thereby, reduces the risk of relapse over time. Data from the first Phase IIb clinical study showed compelling evidence that Relapsing Remitting MS patients treated with Tovaxin saw overall clinical, MRI, and immunological benefits over the placebo group, including statistical significance for decrease in the Annualized Relapse Rate (ARR), improvement in disability score (EDSS), and improvement in quality of life measures (MSQLI), as well as an excellent safety profile with no serious adverse events related to Tovaxin treatment.
SPEEDUS CORPORATION (NASDAQ: SPDE) "Up 283.95% on Friday" Speedus Corp., through its subsidiaries, engages in healthcare, restaurant, and wireless businesses in the United States. The company has co-invested with Siemens Corporate Research, Inc., a subsidiary of Siemens Corporation, in Zargis Medical Corp. to develop advanced diagnostic decision support products and services that automatically analyze acoustical data from a patient to determine physiologically significant features useful in medical diagnosis for primary care physicians, pediatricians, cardiologists, and other healthcare professionals. It owns 90% of F&B Gudtfood, the creator and operator of the original Eurocentric cafe, which operates a store in Manhattan. The company has a portfolio of patents that provide high-speed wireless communication systems. In addition, it offers Local Multipoint Distribution Service (LMDS) license for developing and deploying LMDS technology that is used for various fixed wireless purposes, including wireless local loop telephony, high-speed Internet access, and two-way teleconferencing. The company, formerly known as SPEEDUS.COM, Inc., was founded in 1995 and is based in New York, New York.
LAND STAR INCORPORATED (OTC: LDSR) "Up 168.75% on Friday" Land Star, Inc. operates as a polymer redeployment and polymer reactivation company. Through its majority owned subsidiary, Rebound Rubber Corporation, the company develops certain technology rights for the recycling of rubber. It also, along with its subsidiary PolyTek Rubber & Recycling, Inc., produces crumb rubber using reduction technologies, including ambient grind, cryogenic, and wet grind systems. Land Star also maintains exclusive North American rights to a proven devulcanization technology, which fundamentally changes the way recycled rubber is used. This technology creates a new raw material, Activated Modified Rubber, which may be compounded with natural and synthetic rubber or used directly in new vulcanized products.
OPTIGENEX INCORPORATED (OTC: OPGX) "Up 66.67% on Friday" Optigenex inc. is a formulator, distributor and provider of proprietary next generation skin care, supplements and bulk ingredient featuring AC-11® (Formerly known as C-MED-100®) a patented compound as it core product. AC- 11® is the bioactive, water soluble form of the medicinal herb Uncaria tomentosa.
About OTCPicks.com OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions. Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release. OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
